Legal & General Group PLC Oramed Pharmaceuticals Inc. Transaction History

Legal & General Group PLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$4.6 - $9.91 $13,901 - $29,948	-3,022 Closed	0 $0
Q2 2022 Aug 22, 2022	SELL	$3.72 - $9.0 $58,478 - $141,480	-15,720 Reduced 83.88%	3,022 $14,000
Q1 2022 May 16, 2022	BUY	$8.19 - $13.89 $18,886 - $32,030	2,306 Added 14.03%	18,742 $162,000
Q4 2021 Feb 14, 2022	BUY	$12.98 - $29.75 $172,049 - $394,336	13,255 Added 416.69%	16,436 $234,000
Q3 2021 Nov 15, 2021	BUY	$12.13 - $23.82 $4,294 - $8,432	354 Added 12.52%	3,181 $70,000

Q2 2021 Aug 12, 2021	BUY	$8.34 - $14.59 $23,577 - $41,245	2,827 New	2,827 $38,000

5.69M

8.3K

2.7K

Ticker ORMP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 38,827,100
Market Cap $97.8M
Description
Oramed Pharmaceuticals Inc. engages in the research and development of pharmaceutical solutions for the treatment of diabetes and for the use of orally ingestible capsules or pills for delivery of polypeptides. Its proprietary flagship product is the ORMD-0801, an orally ingestible insulin capsule, which completed phase II clinical trials for th...

Get notified when there are updates to the investment portfolio of Legal & General Group PLC, based on Form 13F filings with the SEC.

Stay updated on Legal & General Group PLC with notifications on news.